Overview
Ethionamide resistance is a form of multidrug-resistant tuberculosis (MDR-TB) that complicates treatment regimens. The World Health Organization (WHO) End TB Strategy emphasizes universal access to drug susceptibility testing (DST) to guide treatment decisions 1.Diagnosis
Xpert MTB/XDR is a rapid nucleic acid amplification test that can detect Mycobacterium tuberculosis* and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin in pulmonary tuberculosis specimens 1.Management
Key Recommendations
References
1 Pillay S, Steingart KR, Davies GR, Chaplin M, De Vos M, Schumacher SG et al.. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. The Cochrane database of systematic reviews 2022. link